List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 158 studies with search of:   Open Studies | New Zealand
Include studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Not yet recruiting The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Conditions: Atherosclerosis;   Cardiovascular Disease;   Coronary Heart Disease;   CV Risk
Interventions: Drug: Darapladib;   Drug: Placebo
2 Recruiting A Phase II, Multicenter, Randomized, Placebo -Controlled, Study To Evaluate The Efficacy and Safety Of Intramuscular Peramivir 600 mg In Subjects With Uncomplicated Acute Influenza
Condition: Acute, Uncomplicated Human Influenza
Interventions: Drug: Peramivir;   Drug: Placebo
3 Recruiting Efficacy and Safety of Drotrecogin Alfa (Activated) in Adult Patients With Septic Shock
Condition: Sepsis
Interventions: Drug: Drotrecogin alfa (activated);   Drug: Placebo
4 Recruiting A Study of RO4607381 in Stable Coronary Heart Disease Patients With Recent Acute Coronary Syndrome
Condition: Coronary Heart Disease
Interventions: Drug: RO4607381;   Drug: Placebo;   Drug: Evidence-based medical care for Acute Coronary Syndrome
5 Recruiting Double-Blind Study of Denosumab Compared With Zoledronic Acid in the Treatment of Bone Metastases in Men With Hormone-Refractory Prostate Cancer
Condition: Bone Metastases in Men With Hormone-Refractory Prostate Cancer
Interventions: Drug: denosumab;   Drug: zoledronic acid
6 Recruiting Once - Daily Oral Direct Factor Xa Inhibitor Rivaroxaban In The Long-Term Prevention Of Recurrent Symptomatic Venous Thromboembolism In Patients With Symptomatic Deep-Vein Thrombosis Or Pulmonary Embolism. The Einstein-Extension Study
Condition: Venous Thromboembolism
Interventions: Drug: Rivaroxaban (BAY59-7939);   Drug: Placebo
7 Not yet recruiting A Prospective, Multi-Center Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™)
Conditions: Atherosclerosis;   Coronary Artery Disease
Intervention: Device: PROMUS Element™
8 Recruiting ALTTO(Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation)Study; BIG 2-06/N063D
Condition: Breast Cancer
Intervention: Drug: Lapatinib
9 Recruiting A Study Testing the Effectiveness of Nesiritide in Patients With Acute Decompensated Heart Failure
Condition: Heart Decompensation
Interventions: Drug: Placebo;   Drug: Nesiritide
10 Recruiting A Study to Evaluate the Efficacy and Safety of Certolizumab Pegol for Induction of Remission in Patients With Crohn's Disease
Condition: Crohn Disease
Interventions: Biological: certolizumab pegol (CDP870);   Other: Placebo
11 Recruiting Randomized, Double-Blind Study Comparing Once Daily Oral Rivaroxaban With Adjusted-Dose Oral Warfarin for the Prevention of Stroke in Subjects With Non-Valvular Atrial Fibrillation
Conditions: Atrial Fibrillation;   Stroke
Interventions: Drug: Rivaroxaban (BAY59-7939);   Drug: Warfarin
12 Recruiting VITATOPS: A Study of VITAmins TO Prevent Stroke
Conditions: Stroke;   Transient Ischemic Attack
Interventions: Other: folic acid;   Dietary Supplement: Vitamin B6;   Dietary Supplement: Vitamin B12
13 Recruiting Trial to Assess the Effects of SCH 530348 in Preventing Heart Attack and Stroke in Patients With Atherosclerosis (TRA 2°P - TIMI 50) (Study P04737)
Conditions: Atherosclerosis;   Ischemia;   Myocardial Infarction;   Cerebrovascular Accident
Interventions: Drug: SCH 530348;   Drug: Placebo
14 Recruiting Oral Direct Factor Xa Inhibitor Rivaroxaban In Patients With Acute Symptomatic Pulmonary Embolism With Or Without Symptomatic Deep-Vein Thrombosis: Einstein-PE Evaluation
Condition: Pulmonary Embolism
Interventions: Drug: Rivaroxaban (BAY59-7939);   Drug: Enoxaparin followed by VKE
15 Recruiting DORADO-AC - Optimized Doses of Darusentan as Compared to an Active Control in Resistant Hypertension
Condition: Hypertension
Intervention: Drug: darusentan (LU 135252), guanfacine, and placebo
16 Recruiting Oral Direct Factor Xa Inhibitor Rivaroxaban In Patients With Acute Symptomatic Deep-Vein Thrombosis (DVT) Without Symptomatic Pulmonary Embolism: Einstein-DVT Evaluation
Condition: Deep Vein Thrombosis
Interventions: Drug: Rivaroxaban (BAY59-7939);   Drug: Enoxaparin followed by VKE
17 Recruiting Post-Operative Concurrent Chemo-Radiotherapy Versus Post-Operative Radiotherapy for Cancer of the Head and Neck
Condition: Skin Cancer
Interventions: Drug: Carboplatin;   Radiation: Radiotherapy
18 Recruiting A Comparison of Prasugrel and Clopidogrel in Acute Coronary Syndrome Subjects
Condition: Acute Coronary Syndrome
Interventions: Drug: Clopidogrel;   Drug: Prasugrel;   Drug: Commercially-available Aspirin
19 Recruiting Safety and Efficacy of BI 1356 as Monotherapy or in Combination in Type 2 DM
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: BI 1356;   Drug: Pioglitazone
20 Recruiting FOLFOX Plus SIR-SPHERES MICROSPHERES Versus FOLFOX Alone in Patients With Liver Mets From Primary Colorectal Cancer
Conditions: Colorectal Cancer;   Colorectal Carcinoma;   Liver Metastases
Interventions: Drug: Systemic chemotherapy (FOLFOX);   Device: SIR-Spheres yttrium-90 microspheres;   Drug: Systemic chemotherapy (FOLFOX)

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services